NYXH

시간 외 거래: 3.16 -0.010 -0.32%

Nyxoah Sa (NYXH)

개요 뉴스 가격 이력 토론 예측

Relative Volume:

Nyxoah Sa Stock (NYXH) Company Profile

Healthcare (1116)

최신 SEC 제출 서류

NYXH's Discussions on Twitter

Compare NYXH vs ISRG, BDX, ALC, MDLN, RMD

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
NYXH Nyxoah Sa	3.17	127.49M	11.51M	-101.84M	-82.98M	-2.6714
ISRG Intuitive Surgical Inc	464.45	163.73B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	156.34	44.73B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	75.51	36.73B	10.40B	980.00M	1.61B	1.9749
MDLN Medline Inc	44.00	36.12B	28.43B	1.16B	1.26B	1.4457
RMD Resmed Inc	222.85	32.70B	5.40B	1.49B	1.78B	10.12

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-07-31	개시	H.C. Wainwright	Buy
2023-07-19	개시	Robert W. Baird	Neutral
2022-04-21	개시	Oppenheimer	Outperform
2022-04-06	개시	Wolfe Research	Peer Perform
2021-12-21	재개	Cantor Fitzgerald	Overweight
2021-07-28	개시	Cantor Fitzgerald	Overweight

Nyxoah Sa 주식(NYXH)의 최신 뉴스

Nyxoah Sa (NYXH) 재무 분석

Nyxoah Sa (NYXH)

Nyxoah Sa Stock (NYXH) Company Profile

Compare NYXH vs ISRG, BDX, ALC, MDLN, RMD

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

Nyxoah Sa 주식(NYXH)의 최신 뉴스

Exit Recap: Will Nyxoah SA benefit from AI trendsEarnings Performance Report & Fast Exit Strategy with Risk Control - baoquankhu1.vn

Nyxoah SA (NASDAQ:NYXH) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Cantor Fitzgerald Initiates Nyxoah SA(NYXH.US) With Buy Rating, Announces Target Price $11 - 富途牛牛

[20-F] Nyxoah SA Files Annual Report (Foreign Issuer) | NYXH SEC FilingForm 20-F - Stock Titan

Bull Run: Can Nyxoah SA ride the EV waveShare Buyback & Accurate Buy Signal Notifications - baoquankhu1.vn

Retail Trends: Is now the right time to enter Nyxoah SAMarket Risk Analysis & Long-Term Safe Return Strategies - baoquankhu1.vn

Breakout Zone: Is Nyxoah SA a speculative investment2026 Rallies & Entry Point Strategy Guides - baoquankhu1.vn

Nyxoah sees Q2 revenue up 73%, plans R&D shift to U.S. and Belgium; shares rise - MSN

Cantor Fitzgerald Reiterates Overweight Rating for NYXH, Price T - gurufocus.com

Cantor Fitzgerald reiterates Nyxoah stock rating on U.S. launch - Investing.com UK

Nyxoah's (NYXH) Overweight Rating Reaffirmed at Cantor Fitzgerald - MarketBeat

Stifel Maintains Nyxoah SA(NYXH.US) With Buy Rating, Cuts Target Price to $10 - 富途牛牛

New Highs: Will Nyxoah SA benefit from rising consumer demandQuarterly Risk Review & Reliable Intraday Trade Plans - baoquankhu1.vn

Nyxoah SA (NYXH) reports Q4 loss, misses revenue estimates - MSN

Nyxoah Details Early U.S. Genio Launch, Reimbursement Update at Oppenheimer MedTech Conference 2026 - marketbeat.com

Nyxoah (ENXTBR:NYXH) Losses Of €90 Million Keep Bearish Cash Runway Concerns In Focus - simplywall.st

Nyxoah Discloses Taub Group’s 10.14% Stake After Threshold Crossing - TipRanks

Publication relating to transparency notifications - GlobeNewswire

Stifel Nicolaus Issues Pessimistic Forecast for Nyxoah (NASDAQ:NYXH) Stock Price - MarketBeat

Nyxoah (NYXH) Q4 2025 Earnings Call Transcript - AOL.com

NYXH Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Nyxoah SA (NYXH) Q4 2025 Earnings Call Highlights: U.S. Launch Success and Financial Challenges By GuruFocus - Investing.com Canada

Nyxoah (NASDAQ:NYXH) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat

Nyxoah Q4 2025 Earnings Call Transcript - MarketBeat

Nyxoah SA reports results for the quarter ended December 31Earnings Summary - TradingView

NYXH: FDA approval and U.S. launch fueled 122% revenue growth and strong Q4 momentum - TradingView

Nyxoah Q4 Earnings Call Highlights - MarketBeat

Nyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

NYXH: Transformative U.S. launch drove 122% revenue growth and strong Q4 momentum - TradingView

Nyxoah Leverages First Full U.S. Sales Quarter to Power Triple-Digit 2025 Revenue Growth - TipRanks

Nyxoah (NASDAQ: NYXH) doubles 2025 revenue as U.S. launch drives growth but losses deepen - Stock Titan

Nyxoah SA Provides Revenue Guidance for the First Quarter and Second Quarter of 2026 - marketscreener.com

Nyxoah SA (NYXH) Posts Fourth Quarter Loss, Falls Short of Revenue Expectations - bitget.com

Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - news.futunn.com

What is the long term forecast for Nyxoah SA stockWeekly Trade Summary & AI Driven Stock Movement Reports - baoquankhu1.vn

Earnings To Watch: Nyxoah SA (XBRU:NYXH) Reports Q4 2025 Result - gurufocus.com

Nyxoah SA expected to post a loss of 53 cents a shareEarnings Preview - tradingview.com

Earnings Preview: Nyxoah SA to Report Financial Results on March 19 - 富途牛牛

Publication relating to transparency notification - GlobeNewswire

Nyxoah price target lowered to EUR 5 from EUR 7 at Baird - MSN

Nyxoah (NYXH) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan

Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference - GlobeNewswire

Trading Recap: Will Nyxoah SA benefit from rising consumer demandShare Buyback & Target Return Focused Picks - baoquankhu1.vn

Will Nyxoah SA benefit from rising consumer demandJuly 2025 Gainers & AI Driven Stock Movement Reports - baoquankhu1.vn

Technical Analysis: Does Nyxoah SA have a competitive edgeJuly 2025 Final Week & Safe Capital Growth Trade Ideas - baoquankhu1.vn

Aug Ideas: Can Nyxoah SA sustain its profitabilityPortfolio Growth Summary & Low Drawdown Investment Strategies - baoquankhu1.vn

Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026 - The Manila Times

Nyxoah SA (NASDAQ:NYXH) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Cantor Fitzgerald Upgrades Nyxoah (NASDAQ:NYXH) to "Strong-Buy" - MarketBeat

Nyxoah (NYXH) Expected to Announce Earnings on Thursday - MarketBeat

Nyxoah SA (NASDAQ:NYXH) Short Interest Down 17.8% in February - MarketBeat

Nyxoah Sa (NYXH) 재무 분석

매출

순이익

현금흐름

주당 순 이익

NYXH과 유사한 종목